Valeria Ruman
About Valeria Ruman
Valeria Ruman is a Clinical Site Monitor at Bristol-Myers Squibb in New Jersey with over 15 years of experience in the pharmaceutical industry.
Current Position at Bristol-Myers Squibb
Valeria Ruman is currently employed as a Clinical Site Monitor at Bristol-Myers Squibb. Based in New Jersey, United States, she plays a crucial role in overseeing clinical trials and ensuring compliance with regulatory standards. Her responsibilities include monitoring clinical sites to ensure adherence to protocols, verifying data, and ensuring the safety and well-being of participants. With over a decade of experience in this role, her expertise is significant in the operational aspects of clinical trials.
Previous Roles at Bristol-Myers Squibb
Valeria Ruman has held multiple roles at Bristol-Myers Squibb. From 2009 to 2011, she served as a Clinical Trial Assistant (CTA) and Study Start-Up Specialist in New Jersey, United States. During this period, she was involved in assisting with clinical trials and managing the initial phases of study start-ups, which includes participant recruitment, site selection, and initiation visits. Her experience in these roles has contributed to her comprehensive understanding of the clinical trial process.
Experience at Alcon, a Novartis Company
Prior to her tenure at Bristol-Myers Squibb, Valeria Ruman worked at Alcon, a Novartis Company, as a Regulatory Manager from 2006 to 2009. Based in Fort Worth, Texas, United States, she was responsible for regulatory management tasks, including compliance with regulatory standards, documentation preparation, and liaison with regulatory authorities. Her three years at Alcon have equipped her with vital regulatory expertise that complements her clinical monitoring skills.
Pharmaceutical Industry Experience
Valeria Ruman has accumulated over 15 years of experience in the pharmaceutical industry. Her career has spanned various roles focused on clinical site monitoring, regulatory management, clinical trial assistance, and study start-up specialization. This extensive background has provided her with a well-rounded perspective on the pharmaceutical industry's operational and regulatory landscape.